Clinical and Translational Oncology

, Volume 12, Issue 11, pp 753–759

SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

  • Cristina Quero Blanco
  • Ramón García Arroyo
  • Mariano Provencio Pulla
  • Antonio Rueda Domínguez
  • Dolores Isla Casado
Clinical Guides in Oncology

DOI: 10.1007/s12094-010-0591-8

Cite this article as:
Quero Blanco, C., García Arroyo, R., Provencio Pulla, M. et al. Clin Transl Oncol (2010) 12: 753. doi:10.1007/s12094-010-0591-8


Hodgkin’s lymphoma is a malignant disease with an incidence of 2.2 cases/100,000. The main goals of staging are to measure the extent of disease and associated prognostic factors. Distinct recommendations were produced for initial work-up, first-line therapy of early and advanced stage disease and treatment of relapsed or resistant patients.


Hodgkin’s lymphomaClinical guidelineEarly-stageAdvanced-stageFavourable prognosisUnfavourable prognosis

Copyright information

© Feseo 2010

Authors and Affiliations

  • Cristina Quero Blanco
    • 1
  • Ramón García Arroyo
    • 2
  • Mariano Provencio Pulla
    • 3
  • Antonio Rueda Domínguez
    • 4
  • Dolores Isla Casado
    • 5
  1. 1.Servicio de Oncología MédicaHospital Clínico Universitario Virgen de la VictoriaMálagaSpain
  2. 2.Servicio de Oncología MédicaComplejo HospitalarioPontevedraSpain
  3. 3.Servicio de Oncología MédicaHospital Universitario Puerta de HierroMajadahonda, MadridSpain
  4. 4.Servicio de Oncología MédicaHospital Costa del Sol de MarbellaMarbella, MálagaSpain
  5. 5.Servicio de Oncología MédicaHospital Clínico Universitario Lozano BlesaZaragozaSpain